granisetron has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, K; Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Kuroishi, S; Masuda, M; Nakamura, Y; Suda, T; Suzuki, S; Toyoshima, M; Watanabe, H; Yamada, T; Yokomura, K | 1 |
| Endo, M; Murakami, H; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Azanza, JR; Blanco-Prieto, MJ; Cabello, JP; Campanero, MA; Ceballos, J; de la Cruz, S; Fernandez Gallego, V; Garcia-Foncillas, J; Gil-Aldea, I; Gurpide, A; Lopez-Picazo, JM; Martin-Algarra, S; Olier Garate, C; Perez-Gracia, JL; Reyna, C; Sadaba, B | 1 |
| Fukuoka, M; Hirashima, T; Iida, K; Kusunoki, Y; Masuda, N; Matsui, K; Miyawaki, H; Takada, M; Tamura, K; Tsukada, H; Ushijima, S; Yana, T; Yoshida, T | 1 |
| Endo, K; Ichimura, H; Inoue, S | 1 |
5 trial(s) available for granisetron and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Paclitaxel; Pemetrexed; Vomiting | 2016 |
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Immunoenzyme Techniques; Japan; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Morpholines; Nausea; Small Cell Lung Carcinoma; Substance P; Vomiting; Young Adult | 2011 |
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy.
Topics: Administration, Oral; Antiemetics; Antineoplastic Agents; Area Under Curve; Biological Availability; Carcinoma, Non-Small-Cell Lung; Cross-Over Studies; Female; Follow-Up Studies; Granisetron; Humans; Injections, Intravenous; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Platinum Compounds; Time Factors; Vomiting | 2007 |
Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chi-Square Distribution; Cisplatin; Colonic Neoplasms; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Injections, Intravenous; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prochlorperazine; Prospective Studies; Statistics, Nonparametric; Time Factors; Vomiting | 1996 |
[Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mitomycin; Personality; Vindesine; Vomiting, Anticipatory | 1999 |